During the past decade, Wonkwang University Hospital conducted 27 clinical trials. In the 10-year time frame, 27 clinical trials started and 12 clinical trials were completed, i.e. on average, 44.4% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 8 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wonkwang University Hospital" #1 sponsor was "Bukwang Pharmaceutical" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Seoul National University Hospital" with 3 trials sponsored and "Asan Medical Center" with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wonkwang University Hospital" #1 collaborator was "CardioVascular Research Foundation, Korea" with 3 trials as a collaborator, "Abbott" with 2 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Korea Institute of Oriental Medicine" with 1 trials as a collaborator and "Korea Otsuka Pharmaceutical Co., Ltd." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Wonkwang University Hospital" are "Coronary Artery Disease" (4 trials), "Hepatitis B" (4 trials), "Breast Cancer" (3 trials), "Acute Coronary Syndrome" (2 trials) and "Atrial Fibrillation" (2 trials). Many other conditions were trialed in "Wonkwang University Hospital" in a lesser frequency.

Most popular intervention types in "Wonkwang University Hospital" are "Drug" (27 trials), "Device" (10 trials), "Procedure" (5 trials), "Biological" (1 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Lansoprazole" (4 trials), "Lansoprazole Placebo" (4 trials), "Aspirin" (2 trials), "Bismuth-Containing Quadruple Therapy" (2 trials) and "Clevudine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Wonkwang University Hospital" are 43 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Wonkwang University Hospital". undefined are not yet recruiting, 6 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 25 completed trials in Wonkwang University Hospital, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Wonkwang University Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 4 trials that are defined as “Not Applicable".